Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials.
Am J Respir Crit Care Med. 2012 Oct 15;186(8):712-5. doi: 10.1164/rccm.201206-1010PP. Epub 2012 Jul 12.
Am J Respir Crit Care Med. 2012.
PMID: 22798316